Clinical Trials
7 trialsNCT05681039 2026-05-05
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06532279 2026-05-04
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NRG Oncology
Phase 2 Recruiting
NCT06097468 2026-04-13
Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
University of California, San Francisco
Phase 1/2 Recruiting
NCT07512921 2026-04-06
BIOMATCH
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT05031910 2026-02-17
Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
Thomas Jefferson University
Phase NA Recruiting
NCT06995508 2026-02-17
Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial
Roswell Park Cancer Institute
Phase 2 Recruiting
NCT06367257 2025-04-10
App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
University of Erlangen-Nürnberg Medical School
Phase NA Recruiting